KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) Inventory Average (2021 - 2025)

Moderna (MRNA) has disclosed Inventory Average for 5 consecutive years, with $242.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Inventory Average fell 8.32% to $242.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $242.5 million, a 8.32% decrease, with the full-year FY2025 number at $135.0 million, down 15.36% from a year prior.
  • Inventory Average was $242.5 million for Q4 2025 at Moderna, down from $286.0 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $2.0 billion in Q3 2022 to a low of $122.5 million in Q1 2025.
  • A 5-year average of $729.6 million and a median of $487.0 million in 2021 define the central range for Inventory Average.
  • Peak YoY movement for Inventory Average: soared 525.32% in 2022, then tumbled 77.23% in 2023.
  • Moderna's Inventory Average stood at $1.2 billion in 2021, then increased by 25.77% to $1.5 billion in 2022, then crashed by 77.23% to $344.5 million in 2023, then dropped by 23.22% to $264.5 million in 2024, then decreased by 8.32% to $242.5 million in 2025.
  • Per Business Quant, the three most recent readings for MRNA's Inventory Average are $242.5 million (Q4 2025), $286.0 million (Q3 2025), and $184.0 million (Q2 2025).